Outcomes After Decompressive Surgery for Severe Cerebral Venous Sinus Thrombosis Associated or Not Associated with Vaccine-Induced Immune Thrombosis with Thrombocytopenia : A Multicenter Cohort Study
© 2023. The Author(s)..
BACKGROUND: Clinical observations indicated that vaccine-induced immune thrombosis with thrombocytopenia (VITT)-associated cerebral venous sinus thrombosis (CVST) often has a space-occupying effect and thus necessitates decompressive surgery (DS). While comparing with non-VITT CVST, this study explored whether VITT-associated CVST exhibits a more fulminant clinical course, different perioperative and intensive care unit management, and worse long-term outcome.
METHODS: This multicenter, retrospective cohort study collected patient data from 12 tertiary centers to address priorly formulated hypotheses concerning the clinical course, the perioperative management with related complications, extracerebral complications, and the functional outcome (modified Rankin Scale) in patients with VITT-associated and non-VITT CVST, both with DS.
RESULTS: Both groups, each with 16 patients, were balanced regarding demographics, kind of clinical symptoms, and radiological findings at hospital admission. Severity of neurological symptoms, assessed with the National Institute of Health Stroke Scale, was similar between groups at admission and before surgery, whereas more patients with VITT-associated CVST showed a relevant midline shift (≥ 4 mm) before surgery (100% vs. 68.8%, p = 0.043). Patients with VITT-associated CVST tended to undergo DS early, i.e., ≤ 24 h after hospital admission (p = 0.077). Patients with VITT-associated CVST more frequently received platelet transfusion, tranexamic acid, and fibrinogen perioperatively. The postoperative management was comparable, and complications were evenly distributed. More patients with VITT-associated CVST achieved a favorable outcome (modified Rankin Scale ≤ 3) at 3 months (p = 0.043).
CONCLUSIONS: Although the prediction of individual courses remains challenging, DS should be considered early in VITT-associated CVST because an overall favorable outcome appears achievable in these patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
|---|---|
| Enthalten in: |
Neurocritical care - 40(2024), 2 vom: 17. März, Seite 621-632 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pelz, Johann Otto [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 25.03.2024 Date Revised 25.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s12028-023-01782-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359984541 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359984541 | ||
| 003 | DE-627 | ||
| 005 | 20240325234229.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12028-023-01782-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1346.xml |
| 035 | |a (DE-627)NLM359984541 | ||
| 035 | |a (NLM)37498459 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pelz, Johann Otto |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Outcomes After Decompressive Surgery for Severe Cerebral Venous Sinus Thrombosis Associated or Not Associated with Vaccine-Induced Immune Thrombosis with Thrombocytopenia |b A Multicenter Cohort Study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.03.2024 | ||
| 500 | |a Date Revised 25.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a BACKGROUND: Clinical observations indicated that vaccine-induced immune thrombosis with thrombocytopenia (VITT)-associated cerebral venous sinus thrombosis (CVST) often has a space-occupying effect and thus necessitates decompressive surgery (DS). While comparing with non-VITT CVST, this study explored whether VITT-associated CVST exhibits a more fulminant clinical course, different perioperative and intensive care unit management, and worse long-term outcome | ||
| 520 | |a METHODS: This multicenter, retrospective cohort study collected patient data from 12 tertiary centers to address priorly formulated hypotheses concerning the clinical course, the perioperative management with related complications, extracerebral complications, and the functional outcome (modified Rankin Scale) in patients with VITT-associated and non-VITT CVST, both with DS | ||
| 520 | |a RESULTS: Both groups, each with 16 patients, were balanced regarding demographics, kind of clinical symptoms, and radiological findings at hospital admission. Severity of neurological symptoms, assessed with the National Institute of Health Stroke Scale, was similar between groups at admission and before surgery, whereas more patients with VITT-associated CVST showed a relevant midline shift (≥ 4 mm) before surgery (100% vs. 68.8%, p = 0.043). Patients with VITT-associated CVST tended to undergo DS early, i.e., ≤ 24 h after hospital admission (p = 0.077). Patients with VITT-associated CVST more frequently received platelet transfusion, tranexamic acid, and fibrinogen perioperatively. The postoperative management was comparable, and complications were evenly distributed. More patients with VITT-associated CVST achieved a favorable outcome (modified Rankin Scale ≤ 3) at 3 months (p = 0.043) | ||
| 520 | |a CONCLUSIONS: Although the prediction of individual courses remains challenging, DS should be considered early in VITT-associated CVST because an overall favorable outcome appears achievable in these patients | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Cerebral venous sinus thrombosis | |
| 650 | 4 | |a Decompressive surgery | |
| 650 | 4 | |a Space-occupying infarction | |
| 650 | 4 | |a VITT | |
| 650 | 4 | |a Vaccination | |
| 650 | 4 | |a Vaccine-induced immune thrombosis with thrombocytopenia | |
| 700 | 1 | |a Kenda, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Alonso, Angelika |e verfasserin |4 aut | |
| 700 | 1 | |a Etminan, Nima |e verfasserin |4 aut | |
| 700 | 1 | |a Wittstock, Matthias |e verfasserin |4 aut | |
| 700 | 1 | |a Niesen, Wolf-Dirk |e verfasserin |4 aut | |
| 700 | 1 | |a Lambeck, Johann |e verfasserin |4 aut | |
| 700 | 1 | |a Güresir, Erdem |e verfasserin |4 aut | |
| 700 | 1 | |a Wach, Johannes |e verfasserin |4 aut | |
| 700 | 1 | |a Lampmannn, Tim |e verfasserin |4 aut | |
| 700 | 1 | |a Dziewas, Rainer |e verfasserin |4 aut | |
| 700 | 1 | |a Wiedmann, Markus |e verfasserin |4 aut | |
| 700 | 1 | |a Schneider, Hauke |e verfasserin |4 aut | |
| 700 | 1 | |a Bayas, Antonios |e verfasserin |4 aut | |
| 700 | 1 | |a Christ, Monika |e verfasserin |4 aut | |
| 700 | 1 | |a Mengel, Annerose |e verfasserin |4 aut | |
| 700 | 1 | |a Poli, Sven |e verfasserin |4 aut | |
| 700 | 1 | |a Brämer, Dirk |e verfasserin |4 aut | |
| 700 | 1 | |a Lindner, Dirk |e verfasserin |4 aut | |
| 700 | 1 | |a Pfrepper, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Roth, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Salih, Farid |e verfasserin |4 aut | |
| 700 | 1 | |a Günther, Albrecht |e verfasserin |4 aut | |
| 700 | 1 | |a Michalski, Dominik |e verfasserin |4 aut | |
| 700 | 0 | |a IGNITE Study Group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neurocritical care |d 2004 |g 40(2024), 2 vom: 17. März, Seite 621-632 |w (DE-627)NLM157737888 |x 1556-0961 |7 nnns |
| 773 | 1 | 8 | |g volume:40 |g year:2024 |g number:2 |g day:17 |g month:03 |g pages:621-632 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s12028-023-01782-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 40 |j 2024 |e 2 |b 17 |c 03 |h 621-632 | ||